[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355774-105":59,"doc-detail-355774-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","thromboembolic-events-after-surgery-for-localized-prostate-cancer-incidence-risk-factors-and-survival-outcomes","Thromboembolic Events after Surgery for Localized Prostate Cancer - Incidence, Risk Factors, and Survival Outcomes","","Incidence and outcomes of thromboembolism (TE) after surgery for localized prostate cancer are characterized in an Asian single-center retrospective cohort. Among 4,880 patients treated between March 1, 2002 and December 31, 2019, TE and venous thromboembolism (VTE) cumulative incidences were quantified at 3 months and 2 years. Older age (≥75) and elevated C-reactive protein (≥0.35 mg/dL) predicted higher TE, while older age and pathological venous invasion predicted VTE. VTE, older age, diabetes history, and high Gleason scores were independently linked to poorer survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/thromboembolic-events-after-surgery-for-localized-prostate-cancer-incidence-risk-factors-and-survival-outcomes/355774/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/thromboembolic-events-after-surgery-for-localized-prostate-cancer-incidence-risk-factors-and-survival-outcomes/355774.png","ImageObject",300,407,{"name":92,"@type":93},"Adam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What outcomes were assessed in patients with localized prostate cancer undergoing surgery?","Question",{"text":112,"@type":113},"The study assessed the incidence of thromboembolic events (TE) and venous thromboembolism (VTE), survival outcomes, and related clinical variables.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which factors increased the risk of TE in this cohort?",{"text":117,"@type":113},"Older age (≥75) and elevated C-reactive protein levels (≥0.35 mg/dL) were significant risk factors for increased TE incidence.",{"name":119,"@type":110,"acceptedAnswer":120},"What predicts worse survival after surgery?",{"text":121,"@type":113},"VTE occurrence, older age, diabetes history, and high Gleason scores (≥8) were independently associated with poor survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355774,1790181985,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Thromboembolic Events after Surgery for Localized Prostate Cancer: Incidence, Risk Factors, and Survival Outcomes  \nClinical and Applied Thrombosis/Hemostasis Volume 32: 1–13 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)  \n[DOI: 10.1177/10760296261452901](DOI: 10.1177/10760296261452901)  \n[journals.sagepub.com/home/cat](journals.sagepub.com/home/cat)  \nYongho Noh1,2,* , Hyunkyung Park3,*, Dong-Yeop Shin2, Junshik Hong2, Hyunsoo Cho2, Ja Min Byun2, Youngil Koh2, Seung-Hwan Jeong4, Hyeongdong Yuk4, Sung‐Yong Cho4, Chang Wook Jeong4, Ja Hyeon Ku4, Cheol Kwak4,**, and Inho Kim5**  \nAbstract  \nBackground: The incidence of thromboembolism (TE) is lower in prostate cancer than in other malignancies, but its sequelae are associated with increased mortality. This study investigated the incidence, risk factors, and survival impact of TE in Asian population with localized prostate cancer undergoing surgical management. Methods: This was a single-center retrospective cohort study of 4,880 localized prostate cancer patients who underwent surgical resection between March 1, 2002, and December 31, 2019. TE, venous thromboembolism (VTE), survival outcome, and related clinical variables were analyzed. Results: The3-month TE cumulative incidence was 0.33% and the 3-monthVTE incidence was 0.16%. The 2-year TE and VTE incidence were 0.81% and 0.29%, respectively. Older age (≥75) (Subdistribution Hazard Ratio (SHR) 2.16, P = 0.0155) and an elevated C-reactive protein levels (≥0.35 mg/dL) (SHR 2.91, P = 0.0001) were significant risk factors for an increased incidence ofTE. Older age (SHR 3.67, P = 0.0113) and pathological venous invasion (SHR 5.13, P = 0.0195) were significant risk factors for an increased incidence ofVTE. The occurrence of VTE, older age, a history of diabetes, and high Gleason scores (≥8) were independently associated with poor survival. Conclusions: The incidence of TE was low in this East Asian cohort of surgically treated patients with localized prostate cancer, however, VTE was an independent predictor of worse overall survival. These findings suggest that pharmacological thromboprophylaxis should be reserved for patients identified as being at high-risk for TE, whereas mechanical measures appear sufficient for the general low-risk cohort.  \nKeywords  \nthromboembolism, venous thromboembolism, localized prostate cancer, prostatectomy, survival outcome, East Asian people  \nReceived: 13 October 2025; Revised: 21 April 2026; Accepted: 6 May 2026  \n1Devision of Hematology and Oncology, Department of Internal Medicine, Chung-Ang University Hospital, Seoul, Korea 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea 3Division of Hematology and Oncology, Department of Internal Medicine, Asan Medical Center, Seoul, Korea  \n4Department of Urology, Seoul National University College of Medicine, Seoul, Korea  \n5Department of Internal Medicine, Seoul National University Hospital, Biomedical Research Institute, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea  \n*Yongho Noh and Hyunkyung Park contributed equally to this work. **These authors equally contributed and share senior authorship.  \nCorresponding author:  \nInho Kim, Department of Internal Medicine, Seoul National University Hospital, 101 Daehag-ro, Jongno-gu, Seoul 03080, Korea.  \nEmail: [ihkimmd@snu.ac.kr](ihkimmd@snu.ac.kr)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/n","cbCairGmYIWjJX9g","https://ap.wps.com/l/cbCairGmYIWjJX9g","pdf",3671279,13,"English","# Abstract\n## Background and Objective\n## Methods\n## Results\n## Conclusions\n# Introduction\n## VTE in oncology and cancer-related risks\n## Prostate cancer incidence and known TE/TRE patterns\n## Rationale for an East Asian localized cohort","[{\"question\":\"What outcomes were assessed in patients with localized prostate cancer undergoing surgery?\",\"answer\":\"The study assessed the incidence of thromboembolic events (TE) and venous thromboembolism (VTE), survival outcomes, and related clinical variables.\"},{\"question\":\"Which factors increased the risk of TE in this cohort?\",\"answer\":\"Older age (≥75) and elevated C-reactive protein levels (≥0.35 mg/dL) were significant risk factors for increased TE incidence.\"},{\"question\":\"What predicts worse survival after surgery?\",\"answer\":\"VTE occurrence, older age, diabetes history, and high Gleason scores (≥8) were independently associated with poor survival.\"}]","Thromboembolic Events after Surgery for Localized Prostate Cancer - Incidence, Risk Factors, and Survival Outcomes | PDF",1790120880,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/158053c338cd4f1e476b83988237910f.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c7404943faff904a3f919ecc3934be1.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8233d5afbc20ef466d85ab1ad0f6222.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/960dc385b612577401227003e1171637.webp",980,1306]